The IPO provides a meaningful cash runway for a clinical-stage biotech. Monitor the first few days of trading for price stability and any early clinical data disclosures on LTG-001. This is a pre-revenue company with no approved products; long-term value depends on pipeline execution.
Price Chart
Executive Summary
Latigo Biotherapeutics priced its upsized IPO of 19,200,000 shares at $18.00 per share, raising $345.6 million in gross proceeds. The stock begins trading on Nasdaq on August 7, 2026 under ticker LTGO, with lead underwriters including Goldman Sachs and Jefferies.
Key Financial Metrics
Key Facts
- IPO of 19,200,000 shares at $18.00 per share, upsized from undisclosed original size
- Gross proceeds of $345.6 million before underwriting discounts and expenses
- Underwriters have a 30-day option to purchase up to 2,880,000 additional shares
- Expected to close on August 10, 2026; shares begin trading August 7, 2026 on Nasdaq
- Lead product candidate LTG-001 is an oral Nav1.8 inhibitor for acute pain (non-opioid)
Financial Impact
$345.6M gross proceeds from IPO
Risk Factors
- IPO pricing and trading debut may be volatile; no prior market history for LTGO
- Clinical-stage company with no approved products; LTG-001 is in development for acute pain
- Dilution from IPO shares and potential full exercise of underwriter option
Investment Themes
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3340893 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 3, 2026 7w ago | Press Release | $23.04 $23.73 | ▲ +2.99% | ▲ +3.54% | $15.55 (−32.51%) |
Aug 12, 2026 10w ago | 3 | $19.38 $20.06 | ▲ +3.54% | ▲ +2.84% | $15.55 (−19.74%) |
Aug 10, 2026 11w ago | Insider Cluster | $18.52 $19.38 | ▲ +4.62% | ▲ +4.37% | $15.55 (−16.04%) |
Aug 10, 2026 11w ago | Insider Cluster | $18.52 $19.38 | ▲ +4.62% | ▲ +4.37% | $15.55 (−16.04%) |
Aug 10, 2026 11w ago | Insider Cluster | $18.52 $19.38 | ▲ +4.62% | ▲ +4.37% | $15.55 (−16.04%) |
Aug 10, 2026 11w ago | Insider Cluster | $18.52 $19.38 | ▲ +4.62% | ▲ +4.37% | $15.55 (−16.04%) |
Aug 10, 2026 11w ago | 8-K | $18.52 $19.38 | ▲ +4.62% | ▲ +4.37% | $15.55 (−16.04%) |
Aug 7, 2026 11w ago | EFFECT | $18.25 $18.56 | ▲ +1.70% | ▲ +1.73% | $15.55 (−14.79%) |
Aug 6, 2026 11w ago | 3 | $18.25 $18.56 | ▲ +1.70% | ▲ +1.73% | $15.55 (−14.79%) |
Aug 6, 2026 11w ago | 3 | $18.25 $18.56 | ▲ +1.70% | ▲ +1.73% | $15.55 (−14.79%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers